Saroglitazar for the treatment of hypertriglyceridemia in patients with type 2 diabetes: current evidence

Overview of attention for article published in Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, April 2015

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (80th percentile)
Above-average Attention Score compared to outputs of the same age and source (57th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 8,965 followers.

Saroglitazar's dual lipid and glucose lowering effects,is by raising lipase activity and insulin sensitivity in T2DM https://t.co/0lfbxilpUi

Saroglitazar for the treatment of hypertrig lyceridemia in patients with type 2 diabetes: current evidence http://t.co/2R3WEq1rg0

Saroglitazar for the treatment of hypertrig lyceridemia in patients with type 2 diabetes: current evidence http://t.co/2R3WEq1rg0